Trump announces trade deal with EU following months of negotiations
Investing.com -- JP Morgan downgraded Procter & Gamble (NYSE:PG) to Neutral from Overweight, citing ongoing consumption weakness across key markets and a less compelling margin outlook heading into fiscal 2026.
The firm expects organic sales growth to remain subdued in the near term, as underlying demand in the U.S., Europe, and China continues to soften.
While it acknowledged P&G’s strong execution and a new two-year restructuring plan, JPMorgan said those efforts are unlikely to offset the lack of near-term top-line momentum.
Management recently flagged that P&G may not meet its long-term growth algorithm every year.
JP Morgan now expects 1.9% organic growth in the fiscal fourth quarter, slightly below its prior estimate and above the Street’s 1.7%. Full-year fiscal 2025 growth is forecast at 2.0%, in line with the company’s outlook.
Although cost savings from the restructuring are expected to provide roughly 50 basis points in annual margin support, JP Morgan sees limited upside to earnings without stronger revenue growth.
It projects fiscal 2026 adjusted EPS of $7.08, slightly above consensus, reflecting lower tariff headwinds and expected savings.
The firm set a December 2026 price target of $170, based on a blended multiple in line with large-cap peers.
It said the risk-reward is now balanced, with efficiency gains priced in and consumption trends still lacking a clear recovery timeline.